Comment
doi: 10.1007/s11934-004-0046-2.
The medical therapy of prostatic symptoms trial
Affiliations
- PMID: 15260923
- DOI: 10.1007/s11934-004-0046-2
Item in Clipboard
Comment
The medical therapy of prostatic symptoms trial
Curr Urol Rep.
2004 Aug.
No abstract available
Comment on
-
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656. N Engl J Med. 2003. PMID: 14681504 Clinical Trial.
Similar articles
-
Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trial.World J Urol. 2018 Jun;36(6):921-929. doi: 10.1007/s00345-018-2193-y. Epub 2018 Jan 30. World J Urol. 2018. PMID: 29383480 Clinical Trial.
-
A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.J Urol. 2000 Jul;164(1):65-70. J Urol. 2000. PMID: 10840426 Clinical Trial.
-
Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.J Urol. 2014 Jun;191(6):1828-34. doi: 10.1016/j.juro.2013.12.014. Epub 2013 Dec 14. J Urol. 2014. PMID: 24342143 Clinical Trial.
-
A review of combination therapy in patients with benign prostatic hyperplasia.Clin Ther. 2007 Mar;29(3):387-98. doi: 10.1016/s0149-2918(07)80077-4. Clin Ther. 2007. PMID: 17577460 Review.
-
The role of combination medical therapy in benign prostatic hyperplasia.Int J Impot Res. 2008 Dec;20 Suppl 3:S33-43. doi: 10.1038/ijir.2008.51. Int J Impot Res. 2008. PMID: 19002123 Review.